Forte Biosciences (FBRX) IV elevated into data

Forte Biosciences (NASDAQ: FBRX) September call option implied volatility is at 410, October is at 310; compared to its 52-week range of 87 to 365 into the expected release of FB-401 Phase 2 data in Atopic Dermatitis. Call put ratio 1 call to 1.1 puts.

You May Also Be Interested In

• Netflix (NFLX) call put ratio 2.2 calls to 1 put into quarter results
• Proshares Trust Ultrashort Lehman 20+ Year Treasury (TBT) call put ratio 1 call to 2.9 puts
• Goldman Sachs (GS) call put ratio 1 call to 2 puts into quarter results